Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CS Capital

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$55M
Portfolio companies 10
Rounds per year 0.92
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CS Capital:
Typical Co-investors
CS Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CS Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Akka Venture France, Ile-de-France, Paris
Aon plc England, London, United Kingdom
Arkansas Development Finance Authority Arkansas, Little Rock, United States
Brain Games -
Chicago Venture Summit Chicago, Illinois, United States
Commonwealth Research Commercialization Fund -
Cosmo Bio Japan, Tokyo
Leumi Partners Israel, Tel Aviv, Tel Aviv District
MK Energy and Infrastructure Connecticut, Stamford, United States
Shanghai Jinyi Keji Touzi Youxian Gongsi China, Chongming, Chongming District
The Batchery Angels -
TSK Asturias, Gijón, Spain
University of Chicago New Venture Challenge Chicago, Illinois, United States
View Worldwide Technology China, Guangdong, Zhuhai
WDI GROUP Japan, Tokyo
Weifang Hongtu Ziben China, Japan, Kagoshima Prefecture
Winning Health Technology Group China, Shanghai
Zhejiang Dening Industrial -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biointron

Biotechnology
Health Care
Medical
$77M02 Sep 2022 Shanghai, Shanghai, China

Porton Advanced Solutions

Biotechnology
Genetics
Manufacturing
Pharmaceutical
Therapeutics
$80M21 Aug 2022 Suzhou, Jiangsu, China

Future Vision

Health Care
27 Jun 2022 Shanghai, Shanghai, China

Laekna Therapeutics

Biotechnology
$61M18 May 2022 Shanghai, China

InxMed

Biotechnology
Life Science
$50M03 Mar 2022 Shanghai, China

G7

Fleet Management
Information Technology
Internet of Things
Logistics
Transportation
$200M15 Feb 2022 Dongcheng District, Beijing, China

Tavotek Biotherapeutics

Biopharma
Biotechnology
Life Science
$35M18 Nov 2021 Lower Gwynedd Township, Pennsylvania, United States

Biointron

Biotechnology
Health Care
Medical
28 Jul 2021 Shanghai, Shanghai, China

Ab&B Biotech

Biotechnology
Health Care
Medical
Pharmaceutical
$92M16 Jul 2021 Taizhou, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CS Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: